This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Sector ETFs & Stocks to Shine on Upbeat December Jobs Data
by Sanghamitra Saha
These sector ETFs and stocks should give solid performance in the coming days thanks to upbeat jobs data for the month of December.
Here Are 5 Stocks With Amazing Interest Coverage Ratio
by Zacks Equity Research
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charged on its debt.
Why HCA (HCA) Could Beat Earnings Estimates Again
by Zacks Equity Research
HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is HCA Healthcare (HCA) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (HCA) Outperforming Other Medical Stocks This Year?
Which Stock to Emulate HCA Healthcare (HCA) Success in 2019?
by Zacks Equity Research
While HCA Healthcare (HCA) has been a runaway winner this year, other companies by virtue of strong operating fundamentals are poised for growth in 2019.
3 Medical Stocks Likely to Emulate Illumina's Success in 2019
by Urmimala Biswas
Illumina's (ILMN) gains are indeed staggering. But is it the sole star in the firmament setting benchmarks for others to try and emulate?
Is HCA Holdings (HCA) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Stock Reports for Disney, U.S. Bancorp & EOG Resources
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Disney (DIS), U.S. Bancorp (USB) and EOG Resources (EOG).
Hospital Industry Outlook: High Cost, Shift of Care Pose Concerns
by Zacks Equity Research
The hospital industry should grow on increased demand from an aging population, rising incidence of disease and technological innovation amid shortage of labor and shift of care to a low-cost setting.
Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?
by Sweta Killa
Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.
Healthcare Battered By Texas ACA Ruling
by Zacks Equity Research
Healthcare Battered By Texas ACA Ruling
Healthcare Stocks Take a Hit on Texas ACA Ruling
by Mark Vickery
Throwing out ACA as healthcare law in the U.S. would create plenty of tremors within the healthcare industry -- to say nothing of Insurance, Pharmaceuticals and related business sectors.
The Zacks Analyst Blog Highlights: Intuitive Surgical, HCA Healthcare, Exelon, 3M and Micron
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Intuitive Surgical, HCA Healthcare, Exelon, 3M and Micron
Has HCA Healthcare (HCA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (HCA) Outperforming Other Medical Stocks This Year?
Top Research Reports for Intuitive Surgical, HCA Healthcare & Exelon
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Exelon (EXC).
Acadia Healthcare Down for Second Year, What Awaits in 2019?
by Zacks Equity Research
Shares of Acadia Healthcare (ACHC) seem to have no respite from its high debt and profitability concern in U.K. business.
Should Value Investors Buy HCA Holdings (HCA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights: Anthem, HCA, Dr. Reddy's and UnitedHealth
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Anthem, HCA, Dr. Reddy's and UnitedHealth
Healthcare Takes Wall Street Lead: 4 Picks
by Tirthankar Chakraborty
Continuous innovation and research in the field of biotechnology and an increasingly aged population in the United States are helping whet appetite for healthcare shares.
HCA (HCA) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
HCA (HCA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Is HCA (HCA) Up 8.1% Since Last Earnings Report?
by Zacks Equity Research
HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Looking for Value? Why It Might Be Time to Try HCA Healthcare (HCA)
by Zacks Equity Research
HCA Healthcare (HCA) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
HCA Holdings (HCA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
HCA Holdings (HCA) closed the most recent trading day at $134.81, moving -0.21% from the previous trading session.
Community Health Carries on Hospital Sale for Business Rejig
by Zacks Equity Research
Community Health (CYH) is set to sell hospital units for debt reduction and focusing on profitable business areas.
Are Investors Undervaluing HCA Holdings (HCA) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.